Effect of doxazosin on insulin sensitivity in hypertensive non-insulin dependent diabetic patients

European Journal of Clinical Pharmacology

Volumn 43, Issue 4, 1992, Pages 365-368

  Huupponen, R ^a   Lehtonen, A ^b   Vahatalo M ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU CITY HOSPITAL   (Finland)

^c Turku Health Centre   (Finland)

Author keywords

adverse drug effects; Diabetes mellitus; Doxazosin; Hypertension; insulin sensitivity; non insulin dependent diabetes mellitus; serum lipids

Indexed keywords

DOXAZOSIN; METFORMIN; SULFONYLUREA DERIVATIVE; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; DIET; GLUCOSE METABOLISM; HEART RATE; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; BLOOD PRESSURE; COMPARATIVE STUDY; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DOXAZOSIN; FEMALE; HEART RATE; HUMAN; HYPERTENSION; INFUSIONS, INTRAVENOUS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0026726934     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF02220610     Document Type: Article

References (22)

1. Assessment of insulin sensitivity in vivo
2. The coronary artery paradox: the role of hyperinsulinemia and insulin resistance and implications for therapy
3. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus
4. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease
5. Postsynaptic α1-blockade with terazosin does not modify insulin sensitivity in nonobese normotensive subjects
6. Captopril and insulin sensitivity
7. Sequential infusions of glucose and insulin at prefixed rates: a simple method for assessing insulin sensitivity and insulin responsiveness
8. A comparison of 3 methods for assessing insulin sensitivity in subjects with normal and abnormal glucose tolerance
9. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus
10. Adrenergic receptors in human liver plasma membranes: predominance of beta,- and alpha,-receptor subtypes
11. Lowered levels of serum insulin, glucose and cholesterol in hypertensive patients during treatment with doxazosin
12. Effect of antibypertensive drugs on insulin, glucose and lipid metabolism
13. Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in type 2 (non-insulin-dependent) diabetes
14. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension
15. A comparison of the effects of hydrochlorthiazide and captopril on glucose and lipid metabolism in patients with hypertension
16. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients
17. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups
18. Direct a-adrenergic stimulation of hepatic glucose production in human subjects
19. Resistance to insulin-stimulated-glucose uptake in patients with hypertension
20. Serum insulin in essential hypertension and in peripheral vascular disease
21. Hemodynamic effects at rest and during exercise in long-term treatment with prazosin in chronic congestive heart failure
22. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in mild or moderate hypertension